SCHEMBL15224201

SCHEMBL15224201

NC(=O)CC(=O)N1CCC2CCCCC2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.47
F2 P00734 1/20 0.40
PLG P00747 1/20 0.40
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
ST14 Q9Y5Y6 1/20 0.40
CNR2 P34972 9/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
F13A1 P00488 1/20 0.36
TGM2 P21980 1/20 0.36
TGM1 P22735 1/20 0.36
MBTD1 Q05BQ5 1/20 0.36
L3MBTL3 Q96JM7 1/20 0.36
EPHX2 P34913 2/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15224231 0.86 HSD11B1 (0.45) HSD11B1F2PLGPRSS1PRSS2
SCHEMBL770665 0.86 HSD11B1 (0.47) HSD11B1CNR2POLBF13A1TGM2
SCHEMBL770396 0.84 HSD11B1 (0.46) HSD11B1CNR2MBTD1L3MBTL3EPHX2
SCHEMBL771617 0.84 HSD11B1 (0.49) HSD11B1F2PLGPRSS1PRSS2
SCHEMBL771655 0.83 HSD11B1 (0.51) HSD11B1CNR2POLBMBTD1L3MBTL3
SCHEMBL770302 0.81 PDE4B (0.47) HSD11B1F2PLGPRSS1PRSS2
SCHEMBL770074 0.81 ALDH1A1 (0.50) HSD11B1CNR2POLBEPHX2ALDH1A1
SCHEMBL770743 0.81 SMYD3 (0.48) HSD11B1F2PLGPRSS1PRSS2
SCHEMBL770893 0.80 GNAI3 (0.46) HSD11B1CNR2EPHX2ALDH1A1LMNA
SCHEMBL769788 0.80 NPC1 (0.52) HSD11B1POLBITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2439202-B1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 SALVAT LAB SA (ES) 2016-04-20 EP disclosed
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885F2 3420/4885PLG 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.